| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.4 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.4 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.045 | 0.5 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.13 | 0.5 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |